Immunotherapy Combo Now Approved for First-Line Mesothelioma in EU ...Middle East

Medscape - News
Nivolumab plus ipilimumab showed superior overall survival versus standard-of-care chemotherapy in patients with unresectable malignant mesothelioma. News Alerts

Hence then, the article about immunotherapy combo now approved for first line mesothelioma in eu was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy Combo Now Approved for First-Line Mesothelioma in EU )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News